Inventor · Boston, MA, US

John Hatcher

17Patents

1h-index

23Co-inventors

46Inventor score

Filing activity: Feb 12, 2016 → Oct 20, 2021

Most-cited inventions

Patent	Title	Area	Cited by	Status
US11542251B2	IRAK degraders and uses thereof	Chemistry; Metallurgy	1	Active
US10913744B2	LRRK2 inhibitors and methods of making and using the same	Chemistry; Metallurgy	0	Active
US11858897B2	Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK	Chemistry; Metallurgy	0	Active
US11186574B2	Inhibitors of EGFR and/or HER2 and methods of use	Chemistry; Metallurgy	0	Active
US12157738B2	Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1	Chemistry; Metallurgy	0	Active
US12233128B2	Degraders that target ALK and therapeutic uses thereof	Chemistry; Metallurgy	0	Active
US12325725B2	Cyclin-dependent kinase degraders and methods of use	Chemistry; Metallurgy	0	Active
US10689366B2	Compounds for MALT1 degredation	Chemistry; Metallurgy	0	Active
US11066363B2	Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK	Chemistry; Metallurgy	0	Active
US12275731B2	Azaindole inhibitors of wild-type and mutant forms of LRRK2	Human Necessities	0	Active
US11945816B2	Inhibitors of EGFR and/or HER2 and methods of use	Chemistry; Metallurgy	0	Active
US10508082B2	Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK	Chemistry; Metallurgy	0	Active
US12157741B2	Macrocyclic inhibitors of DYRK1A	Chemistry; Metallurgy	0	Active
US10975055B2	Inhibitors of interleukin-1 receptor-associated kinases and uses thereof	Chemistry; Metallurgy	0	Active
US10711036B2	MALT1 inhibitors and uses thereof	Human Necessities	0	Active
US12410194B2	Potent and selective azaindole inhibitors of CDK8 and CDK19	Chemistry; Metallurgy	0	Active
US11248007B2	Inhibitors of MALT1 and uses thereof	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.